300653.SZ
正海生物
SZSE · Healthcare · C 制造业 · CN
CNY 14.78
−1.92%Margins
Gross margin
86.5%
EBITDA margin
32.2%
EBIT margin
21.6%
Net margin
20.3%
FCF margin
16.4%
7.8%
Return on equity
7.0%
Return on assets
8.3%
Return on invested capital
0.35x
Asset turnover
CNY 71.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026